Microscopic polyangiitis: Clinical aspects and treatment

Annales de Medecine Interne

Volumn 147, Issue 3, 1996, Pages 165-177

  Lhote, François ^a   Cohen, Pascal ^b   Généreau, Thierry ^b   Gayraud, Martine ^b   Guillevin, Loïc ^b  

^a DELAFONTAINE HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

anti neutrophil cytoplasm antibodies; corticosteroids; cyclophosphamide; microscopic polyangiitis; polyarteritis nodosa

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; BONE MARROW SUPPRESSION; CANCER; FEMALE; GLOMERULONEPHRITIS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NECROTIZING ARTERITIS; POLYARTERITIS NODOSA; REVIEW;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; LUNG DISEASES; POLYARTERITIS NODOSA; PROGNOSIS;

EID: 0030016648     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. KÜSSMAUL A, MAIER R : Ueber eine bischer nicht beschriebene eigentümliche Arterienerkrankung (Periarteritis nodosa) die mit Morbus Brightii und rapid forstaschreitender allgemeiner Muskellähmung einhergenht. Dtsch Arch Klin Med 1866 ; 1 : 483-518.
2. SAVAGE COS, WINEARLS CG, EVANS DJ, REES AJ, LOCKWOOD CM : Microscopic polyarteritis : presentation, pathology and prognosis. Q J Med 1985 ; 56 : 467-83.
3. D'AGATi V, CHANDER P, NASH M, MANCILLA JR : Idiopathic microscopic polyarteritis nodosa : ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 1986 ; 7: 95-110.
4. ADU D, HOWIE AJ, SCOTT DGI et al : Polyarteritis and the kidney. Q J Med 1987 ; 62 : 221-37.
5. GORDON M, LUQMANI RA, ADU D et al : Relapses in patients with a systemic vasculitis. Q J Med 1993 ; 86 : 779-89.
6. JENNETTE C, FALK R, ANDRASSY K et al : Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994 ; 37 : 187-92.
7. DAVSON J, BALL, J, PLATT R : The kidney in periarteritis nodosa. Q J Med 1948 ; 17 : 175-202.
8. ZEEK PM : Periarteritis nodosa : a critical review. Am J Clin Pathol 1952 ; 22 : 777-90.
9. FAUCI AS, HAYNES BF, KATZ P : The spectrum of vasculitis : clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978 ; 89 : 660-76.
10. LIGHTFOOT RW, MICHEL BA, BLOCH DA et al : The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990 ; 33 : 1088-93.
11. LIE JT : Illustrated histopathologic classification criteria for selected vasculitic syndromes. Arthritis Rheum 1990 ; 33 : 1074-87.
12. GUILLEVIN L, LHOTE F, JARROUSSE B, FAIN O : Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A metaanalysis of 3 prospective controlled trials including 182 patients over 12 years. Ann Med Intern (Paris) 1992 ; 143 : 405-16.
13. COHEN-TERVAERT JW, KALLEMBERG COM : Neurologic manifestations of systemic vasculitides. Rheum Dis Clin North Am 1993 ; 9 : 913-40.
14. LIE JT : Nomenclature and classification of vasculitis : plus ça change, plus c'est la même chose. Arthritis Rheum 1994 ; 37 : 181-6.
15. GUILLEVIN L, LHOTE F : Distinguishing polyarteritis nodosa from microscopic polyangitis. Curr Opin Rheumatol 1995 ; 7 : 20-4.
16. GOCKE DJ, HSU K, MORGAN C et al : Association betwwen polyarteritis nodosa and Australia antigen. Lancet 1970 ; 2 : 1149-50.
17. TRÉPO C, ZUCKERMAN AJ, BIRD RC, PRINCE AM : The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol 1974 ; 27 : 863-86.
18. SERGENT J, LOCKSHIN M, CHRISTIAN C, GOCKE D : Vasculitis with hepatitis B antigenemia : long term observations in nine patients. Medicine 1976 ; 55 : 1-18.
19. SERRA A, CAMERON JS, TURNER DR et al : Vasculitis affecting the kidney : presentation, histopathology and long-term outcome. Q J Med 1984 ; 53 : 181-207.
20. DAVIES DJ, MORAN JE, NIAL JF, RYAN GB : Segmental necrotizing glomerulonephritis with antineutrophil antibody : possible arbovirus aetiology ? Br Med J 1982 ; 285 : 606.
21. VAN DER WOUD FJ, RASMUSSEN N , LOBATTO S et al : Autoantibodies against neutrophils and monocytes ; tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985 ; 1 : 425-9.
22. MEYER O : The pathogenic role of anti-neutrophil cytoplasm autoantibodies [Editorial]. Am Med Interne (Paris) 1992 ; 143 : 423-5.
23. KALLENBERG CGM : Autoantibodies in vasculitis : current perspectives. Clin Exp Rheumatol 1993 ; 11 : 355-60.
24. HAGEN EC, BAILLEUX BEPB, VAN ES LA, DAHA MR, VAN DER WOUDE FJ : Anti-neutrophil cytoplasm autoantibodies : a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 1993 ; 81 : 1996-2002.
25. SAVAGE COS : Interactions between leukocytes, the vascular endothelium and autoantibodies in the development of systemic vasculitis. Ann Med Interne (Paris) 1993 ; 144 : 353-6.
26. GROSS WL, CSERNOK E : Immunodiagnostic pathophysiologic aspects of anti-neutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995 ; 7 : 11-9.
27. CSERNOK E, SCHMITT WH, ERNST M, BAINTON DF, GROSS WL : Membrane surface proteinase and intra-cytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides. In : GROSS WL, ed. ANCA- associated vasculitis. New York, London : Plenum Press, 1993 : 45-50.
28. VAN VOLLENHOVEN RF : Adhesion molecules, sex steroids, and the pathogenesis of vasculitic syndromes. Curr Opin Rheumatol 1995 ; 7 : 4-10.
29. BRASILE L, KREMER JM, CLARKE JL : Identification of an autoantibody to vascular endothalial cell-specific antigens in patients with systemic vasculitis. Am J Med 1989 ; 87 : 74-80.
30. SAVAGE COS, POTTINGER BE, HASKIN G et al : Vascular damage in Wegener's granulomatosis and microscopic polyarteritis : presence of anti-endothalial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 1991 ; 85 : 14-9.
31. DlRESKENELI H, D'CRUZ D, KHAMASHATA MA, HUGHRS GRV : Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis. Clin Immunol Immunopathol 1994 ; 70 : 206-10.
32. MERONI PL : What is going to happen tomorrow in the field of anti-endothelial cell autoantibodies related vasculitis. Ann Med Interne (Paris) 1994 ; 145 : 467-8.
33. GRAU GE, ROUX-LOMBARD P, GYSLER C et al : Serum cytokine changes in systemic vasculitis. Immunology 1989 ; 68 : 196-8.
34. KELOW J, SZYMKOWIAK CH, STICHERLING M et al : Pro- and anti-inflammatory cytokines in primary systemic vasculitis. In : GROSS WL, ed. ANCA-associated vasculitis. New York, London : Plenum Press, 1993 : 341-4.
35. CID MC, GRAU JM, CASADEMONT J et al : Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with systemic polyarteritis nodosa. Arthritis Rheum 1994 ; 37 : 1055-61.
36. DUPRÉ-GOUDABLE C, SOLER C, OKSMAN F et al : Micropolyartérite. Nephrologie 1992 ; 13 : 283-6.
37. WAINWRIGHT J, DAVSON J : The renal appearances in the microscopic form of periarteritis nodosa. J Pathol Bacteriol 1949 ; 62 : 189-96.
38. HAWORTH SJ, SAVAGE COS, CARR D, HUGHES JM, REES AJ : Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis. Br Med J 1985 ; 290 : 1755-78.
39. NADA AK, TORRES VE, RYU JH et al : Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 1990 ; 65 : 847-56.
40. MATSUMOTO T, HOMMA S, OKADA M et al : The lung in polyarteritis nodosa : a pathologic study of 10 cases. Hum Pathol 1993 ; 24 : 717-24.
41. HAUSCHILD S, SCHMITT WH, CSERNOK E et al : ANCA in systemic vasculitides, collagen vascular disorders and inflammatory bowel diseases. In : GROSS WL, ed. ANCA-associated vasculitis. New York, London : Plenum Press, 1993 : 245-51.
42. LESAVRE P, NOËL LH, CHAUVEAU D, GEFFRIAUD C, GRÜNFELD JP : Antigen specificities and clinical distribution of ANCA in kidney disease. Klin Wochenschr 1991 ; 69 : 552-7.
43. NILES JL : Value of test for antineutrophil cytoplasmic autoantibodies in the diagnosis and treatment of vasculitis. Curr Opin Rheumatol 1993 ; 5 : 18-24.
44. FALK RJ, HOGAN S, CAREYT S et al : Clinical course of antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990 ; 113 : 656-63.
45. GUILLEVIN L, VISSER H, NOËL LH et al : Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome 62 patients. J Rheumatot 1993 ; 20 : 1345-9.
46. PUSEY CD, GASKIN G : Disease association with anti-neutrophil cytoplasmic antibodies. In : GROSS WL, ed. ANCA-associated vasculitis. New York, London : Plenum Press, 1993 : 145-55.
47. GUILLEVIN L, LHOTE F, JARROUSSE B et al : Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients. Ann Mad Interne (Paris) 1992 ; 143 (suppl 1) : 63-74.
48. GUILLEVIN L, LHOTE F, LÉON A, FAUVELLE F, VIVITSKI L, TRÉPO C : Treatment of polyarteritis nodos related to hepatitis B virus with short-term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumutol 1993 ; 20 : 289-98.
49. GUILLEVIN L, LHOTE F, SAUVAGET F et al : Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994 ; 53 : 334-7.
50. BRON KM, STROTT CA, SHAPIRO AP : The diagnostic value of angiographic observations in polyarteritis nodosa. A case of multiple aneurysms in the visceral organs. Arch Intern Med 1965 ; 116 : 450-4.
51. HEKALI P, KAJANDER H, PAJARI R, STENMAN S, SOMER T : Diagnostic significance of angiographically observed visceral aneurysm with regard to polyarteritis nodosa. Acta Radiol 1991 ; 32 : 143-8.
52. BAGENSTOSS AH, SHICK RM, POLLEY HF : The effect of cortisone on the lesions of periarteritis nodosa (abstract). Am J Pathol 1950 ; 26 : 709.
53. FROHNRET PP, SHEPS SG : Long-term follow-up study of periarteritis nodosa. Am J Med 1967 ; 43 : 8-14.
54. COHEN RD, CONN DL, ILSTRUP DM : Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 1980 ; 55 : 148-55.
55. LEIB ES, RESTIVO C, PAULUS HE : Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 1979 ; 67 : 941-7.
56. FAUCI AS, DOPPMAN JL, WOLFF SM : Cyclophosphamide-induced remission in advanced polyarteritis nodosa. Am J Med 1978 ; 64 : 890-4.
57. FAULT AS, KATZ P, HAYNES BF, WOLFF SM : Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 1979 ; 301 : 235-8.
58. GUILLEVIN L, LÊ THI HUONG D, GODEAU P, JAÏS P, WECHSLER B : Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis : a study in 165 patients. Br J Rheumatol 1988 ; 27 : 258-64.
59. CONN DL : Role of cyclophosphamide in treatment of polyarteritis nodosa ? J Rheumatol 1991 ; 18 : 489-90.
60. GUILLEVIN L, JARROUSSE B, LOCK C et al : Long-term follow-up after treatment of periarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchanges and cyclophosphamide to steroids and plasma exchanges. A prospective randomized trial of 71 patients. J Rheumatol 1991 ; 18 : 567-14.
61. GUILLEVIN L, FAIN O, LHOTE F et al : Lack of superiority of steroids and plasma exchanges to steroids in the treatment of polyarteritis nodosa and Churg-Strauss angiitis. A prospective randomized trial in 78 patients. Arthritis Rheum 1992 ; 35 : 208-15.
62. GUILLEVIN L, LHOTE F, CASASSUS P et al : Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medecine 1996 ; 75 : 17-28.
63. CONN DL : Polyarteritis. Rheum Dis Clin North Am 1990 ; 16 : 341-62.
64. ARLET J : De la corticothérapie classique à l'assaut cortisonique. Ann Med Interne (Paris) 1994 ; 145 (suppl 2) : 5-10.
65. RENOUX M, HIULIQUIN P, MRNKES CJ : Les bolus de méthylprednisolone en rhumatologie. Ann Med Interne (Paris) 1994 ; 145 : 133-9.
66. HUFFMAN GS, LEAVITT RY, FAUCI AS : Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum 1989 ; 32 : 1626-7.
67. CUPPS TR : Cyclophosphamide : to pulse or not to pulse. Am J Med 1990 ; 89 : 399-402.
68. STILLWELL TJ, BENSON RC, DEREMEE RA, MCDONALD TJ, WEILAND LH : Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum 1988 ; 31 : 465-70.
69. WARNE GL, FAIRLEY KF, HOBBS JB, MARTIN FIR : Cyclophosphamide-induced ovarian failure. N Engl J Med 1973 ; 289 : 1159-62.
70. BAKER GL, KAML LE, ZEE BC et al : Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987 ; 83: 1-9.
71. GODEAU B, COUTANT-PERONNE V, LÊ THI HUONG D et al : Pneumocystis carinii pneumonia in the course of connective tissue disease : report of 34 cases. J Rheumatol 1994 ; 21 : 246-51.
72. JARROUSSE B, GUILLEVIN L, BINDE P et al : Increased rish of Pneumocystis carinii in patients with Wegener's granulomatosis. Clin Exp Rheumatol 1993 ; 11 : 615-21.
73. BACON PA: Vasculitis. Clinical aspects and therapy. Acta Med Scand 1987 ; suppl 715 : 157-63.
74. DE VITA S, NERI R, BOMBARDIERI S : Cyclophosphamide pulses in the treatment of rheulatic diseases : an update. Clin Exp Rheumatol 1991 ; 9 : 179-93.
75. FORT JG, ABRUZZO JL : Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone. Arthritis Rheum 1988 ; 31 : 1194-8.
76. GUILLEVIN L, LHOTE F, COHEN P et al : Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus steroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective randomized trial in 62 patients. Arthritis Rheum 1995 ; 38 : 1638-45.
77. SCOTT DGI, BACON PA : Intravenous cyclophosphamide plus methylprednisolone treatment in systemic rheumatoid vasculitis. Am J Med 1984 ; 76 : 377-84.
78. GAYRAUD M, LE CLERC P, GUILLEVIN L : Treatment of good-prognosis polyarteritis nodosa (PAN) and Churg-Strauss syndrome (CSS) ; comparison of steroids and two cyclophosphamide regimens (daily oral or monthly pulses) in 25 patients (abstract 1149). Arthritis Rheum 1994 ; 37 (suppl 9) : S352.
79. PUSEY CD, REES AJ, EVANS DJ, PETERS DK, LOCKWOOD CM : Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991 ; 40 : 757-63.
80. SODING PF, LOCKWOOD CM, PARK GR : The intensive care of patients with fulminant vasculitis. Anaesth Intensive Care 1994 ; 22 : 81-9.
81. GASKIN G, SAVAGE COS, RYAN JJ et al : Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991 ; 6 : 689-94.
82. JAYNE DRW, BLACK CM, DAVIES M, FOX C, LOCKWOOD CM : Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991 ; 337 : 1137-9.
83. JAYNE DRW : Intravenous immunoglobulin in the therapy of systemic vasculitis. Transfus Sci 1992 ; 13 : 317-24.
84. MATHIESON PW, COBBOLD SP, HALES G et al : Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med 1990 ;323 : 250-4.
85. LOCKWOOD CM, THIRD S, ISAACS JD, HALE G, WALDMANN H : Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 1993 ; 341 : 1620-2.
86. NEWBUERGER JW, TAKAHASHI M, BURNS JC et al : The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 1986 ; 315 : 341-7.
87. SCHIFFERLI JA : Adverse effects of intravenous immunoglobulins. Transfus Sci 1992 ; 13 : 331-8.
88. RICHTER C, SCHNABEL A, CSERNOK E, REINHOLD-KELLER E, GROSS WL : Treatment of ANCA-associated systemic vasculitis with high-dose intravenous immunoglobulin (abstract 1154). Arthritis Rheum 1994 ; 37 (suppl 9) : S353.